{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["14(15)"],"submitter":["Shen L"],"journal":["Cancer medicine"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12304520"],"repository":["biostudies-literature"],"pubmed_title":["De Novo EGFR ‐ALK and EGFR ‐ROS1 Co‐Mutations in NSCLC: Clinical Characteristics, Molecular Profiling, and Treatment Outcomes From a Retrospective Analysis"],"pmcid":["PMC12304520"],"pubmed_authors":["Shen L","Liu K","Ma L","Liao W","Jiang Q","Gu Q","Deng H"],"additional_accession":[]},"is_claimable":false,"name":"De Novo EGFR ‐ALK and EGFR ‐ROS1 Co‐Mutations in NSCLC: Clinical Characteristics, Molecular Profiling, and Treatment Outcomes From a Retrospective Analysis","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jul","modification":"2026-05-28T22:16:32.019Z","creation":"2025-08-30T03:06:41.188Z"},"accession":"S-EPMC12304520","cross_references":{}}